New drug enters human testing for advanced cancers
Disease control
Recruiting now
This early-stage study aims to find a safe and effective dose of a new drug called CR-001 for adults with advanced solid tumors that have spread. Researchers will test different dose levels in about 290 participants with various cancers to see how the body handles the drug and if…
Phase: PHASE1, PHASE2 • Sponsor: Crescent Biopharma, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC